Furthermore, knockdown of LRP1 in neurons dramatically suppresses tau spread across the brain in the mouse unilaterally injected with AAV expressing human tau with P301L mutant in hippocampus (Rauch et al., 2020), suggesting that LRP1 may represent a novel therapeutic target for tauopathies. Here, LRP1 is linked to tauopathy.